BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30636572)

  • 1. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Feb; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
    Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
    Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Arterial Transit Time Measurement for Evaluating the Hemodynamic Perfusion State of Patients with Chronic Cerebrovascular Stenosis or Occlusive Disease: Correlative Study between MR Imaging and
    Takeuchi K; Isozaki M; Higashino Y; Kosaka N; Kikuta KI; Ishida S; Kanamoto M; Takei N; Okazawa H; Kimura H
    Magn Reson Med Sci; 2023 Jul; 22(3):289-300. PubMed ID: 35545508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
    Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
    Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Blood Flow Improvement after Indirect Revascularization for Pediatric Moyamoya Disease: A Statistical Analysis of Arterial Spin-Labeling MRI.
    Blauwblomme T; Lemaitre H; Naggara O; Calmon R; Kossorotoff M; Bourgeois M; Mathon B; Puget S; Zerah M; Brunelle F; Sainte-Rose C; Boddaert N
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):706-12. PubMed ID: 26585258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/magnetic resonance hybrid scanner imaging of cerebral blood flow using (15)O-water positron emission tomography and arterial spin labeling magnetic resonance imaging in newborn piglets.
    Andersen JB; Henning WS; Lindberg U; Ladefoged CN; Højgaard L; Greisen G; Law I
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1703-10. PubMed ID: 26058699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hemodynamic impairment on
    Hara S; Tanaka Y; Ueda Y; Abe D; Hayashi S; Inaji M; Maehara T; Ishii K; Nariai T
    J Clin Neurosci; 2020 Feb; 72():258-263. PubMed ID: 31843438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.